Alterity Therapeutics Ltd (NASDAQ:ATHE)
| 0.595 Delayed Data As of Mar 30 |  +0.005 / +0.84%Today’s Change | 0.28 Today|||52-Week Range 2.55 | -23.72% Year-to-Date |
Latest ATHE News | Press Releases
No recent news for Alterity Therapeutics Ltd.
Today’s Trading
| Previous close | 0.60 |
| Today’s open | 0.59 |
| Day’s range | 0.55 - 0.65 |
| Volume | 11,748 |
| Average volume (3 months) | 83,087 |
| Market cap | $8.7M |
Data as of 3:57pm ET, 03/30/2020
Growth & Valuation
| Earnings growth (last year) | -19.33% |
| Earnings growth (this year) | +41.76% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNOASonoma Pharmaceutica... | -0.19 | -3.73% |
| IMRNImmuron Ltd | +0.05 | +2.85% |
| TTPHTetraphase Pharmaceu... | -0.36 | -21.95% |
| TCONTRACON Pharmaceutica... | +0.14 | +8.97% |
Data as of 3:59pm ET, 03/31/2020
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$8.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Melbourne, Victoria (vic) |
Forecasts
